Jeffrey Crawford, MD Jeffrey Crawford, MD

Jeffrey Crawford, MD

Medical Oncologist

4.9 out of 5  (204 ratings, 42 reviews)
Duke Health Provider question Circle Img
Insurance

Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.

Below are the plans currently accepted in 2018. There are some changes to the plans accepted beginning January 1, 2019. More information will become available on PlanForDuke.com.

Click to see a list of accepted insurance plansHide accepted insurance plans
Contact
919-681-9509 Office number
919-681-5864
Fax number
Insurance

Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.

Below are the plans currently accepted in 2018. There are some changes to the plans accepted beginning January 1, 2019. More information will become available on PlanForDuke.com.

Click to see a list of accepted insurance plansHide accepted insurance plans

Contact
WHERE I PROVIDE CARE
Profile
ABOUT ME

When someone is faced with a diagnosis of lung cancer, they may be going through surgery, radiation treatment, chemotherapy or enrolling in a clinical trial. It’s a very complicated process to understand what’s involved and what may happen next. It’s also hard to hear all the answers if you’re by yourself. We encourage our patients to come with family members and friends and loved ones and particularly to identify one or two main go-to people in terms of care-giving and support. That way we can engage them in the whole process. Just as we have a team taking care of the patient, the patient has a team, too. At Duke, we have the opportunity to engage patients in the very latest treatment approaches, whether it’s a new surgical technique, the latest radiation approach, or some novel chemotherapy, immunology, or targeted therapy, several of which we’ve been developing. Duke provides patients with a real opportunity that they may not have elsewhere.

LANGUAGES I SPEAK
English
LEARN MORE ABOUT ME
Training
EDUCATION
MD, Ohio State University College of Medicine, 1974
RESIDENCY
Internal Medicine, Duke University Medical Center, 1974-1977
Hematology-Oncology, Duke University Medical Center, 1977-1978, 1979-1981
Medicine, Chief Resident, Duke University Medical Center, 1978-1979
BOARD CERTIFICATION
American Board of Internal Medicine, Hematology/Oncology
American Board of Internal Medicine, Internal Medicine
American Board of Internal Medicine, Medical Oncology
Clinical Focus and Research
MY RESEARCH INTERESTS

My practice involves medical treatment of patients with lung cancer, mesothelioma and other thoracic cancers. I am part of a team including an oncology nurse, physician assistant, pharmacist and counselor. Together we provide state-of-the-art care to our patients involving chemotherapy, targeted treatment, immunotherapy and supportive care. We are part of a larger multidisciplinary group including other medical oncologists, thoracic surgeons, radiation oncologists, pulmonologists, radiologists and pathologists. Whenever possible, we try to provide our patients with the latest technology and treatments, which often involves clinical trials with new and exciting agents that are making a difference in the lives of our patients today.

Ratings and Reviews

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more about our survey process. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Overall provider rating
4.9 out of 5 (204 ratings, 42 reviews)
PATIENT REVIEWS
Patient comments are gathered from our Press Ganey Patient Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
Industry Relationships and Collaborations
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
  • G1 Therapeutics
  • Merck Sharpe & Dohme (Merck & Co, USA)
  • Roche/Genentech